Showing results (171-180 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|March 24, 2025
Association of Perioperative Nursing Care with Incidence of Surgical Site Infections and Short-Term Outcomes in Primary Liver Cancer Patients: A Retrospective Comparison with Standard CareBin Yang, Xiaoyun Guo, Kewen Qi, et al.Therapeutics and Clinical Risk Management|March 18, 2025
Novel Obstetric Air Cushion for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section: A Randomized Controlled Clinical TrialYang Dong, Wei-Wei Cao, Hao Weng, et al.Therapeutics and Clinical Risk Management|March 17, 2025
Clinical Manifestations and Risk Factors of Liver Injury Induced by PD-1 Inhibitors in Patients with Malignancies: A Case-Control StudyPengfei Zhao, Lihong Yu, Wenming Ma, et al.Therapeutics and Clinical Risk Management|March 14, 2013
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimodClaudio Gasperini, Serena Ruggieri, Chiara Rosa Mancinelli, et al.Therapeutics and Clinical Risk Management|March 24, 2012
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysisCurtis L Cooper, Eric Druyts, Kristian Thorlund, et al.Therapeutics and Clinical Risk Management|November 28, 2012
Appropriateness of administration of nasogastric medication and preliminary interventionLing-Ling Zhu, Ling-Cheng Xu, Hui-Qin Wang, et al.Therapeutics and Clinical Risk Management|June 14, 2013
An update of teriflunomide for treatment of multiple sclerosisJiwon Oh, Paul W O'ConnorTherapeutics and Clinical Risk Management|April 27, 2013
Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenacJohn H Peniston, Morris S Gold, Matthew S Wieman, et al.Therapeutics and Clinical Risk Management|October 24, 2009
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancerSerena Ricciardi, Silverio Tomao, Filippo de MarinisTherapeutics and Clinical Risk Management|October 24, 2009
Safety and efficacy of telbivudine for the treatment of chronic hepatitis BMelissa K OsbornPageof 256